The developing zebrafish (Danio rerio): A vertebrate model for high-throughput screening of chemical libraries

Birth Defects Research Part C - Embryo Today: Reviews

Volumn 93, Issue 3, 2011, Pages 268-280

  Lessman, Charles A ^a  

^a University of Memphis   (United States)

Author keywords

Chemical biology; Chemical genetics; High content screens; Structure activity relationship

Indexed keywords

ANTIOBESITY AGENT; CARDIOVASCULAR AGENT; NATURAL PRODUCT;

ANIMAL HUSBANDRY; ANTIMICROBIAL ACTIVITY; BEHAVIORAL SCIENCE; BIOMICS; CANCER SCREENING; DRUG SCREENING; GENETIC ANALYSIS; HEARING; HIGH CONTENT SCREENING; HIGH THROUGHPUT SCREENING; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY POLYCYSTIC DISEASE; MOLECULAR LIBRARY; MUTAGENESIS; NONHUMAN; OBESITY; PHENOTYPE; PRIORITY JOURNAL; REVIEW; SCREENING TEST; STRUCTURE ACTIVITY RELATION; VISION; ZEBRA FISH;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; DISEASE MODELS, ANIMAL; EMBRYO, NONMAMMALIAN; HIGH-THROUGHPUT SCREENING ASSAYS; SMALL MOLECULE LIBRARIES; ZEBRAFISH;

DANIO RERIO; VERTEBRATA;

EID: 80052972631     PISSN: 1542975X     EISSN: 15429768     Source Type: Journal    
DOI: 10.1002/bdrc.20212     Document Type: Review

References (69)

1. Adams KN, Takaki K, Connolly LE, et al. 2011. Drug tolerance in replicating mycobacteria mediated by a macrophage-induced efflux mechanism. Cell 145: 39-53.
2. An WF, Tolliday N. 2010. Cell-based assays for high-throughput screening. Mol Biotechnol 45: 180-186.
3. Baraban S, Taylor M, Castro P, Baier H. 2005. Pentylenetetrazole induced changes in zebrafish behavior, neural activity and c-fos expression. Neuroscience 131: 759-768.
4. Berghmans S, Hunt J, Roach A, Goldsmith P. 2007. Zebrafish offer the potential for a primary screen to identify a wide variety of potential anticonvulsants. Epilepsy Res 75: 18-28.
5. Bowman TV, Zon LI. 2010. Swimming into the future of drug discovery: In vivo chemical screens in zebrafish. ACS Chem Biol 5: 159-161.
6. Brockerhoff SE, Hurley JB, Janssen-Bienhold U, et al. 1995. A behavioral screen for isolating zebrafish mutants with visual system defects. Proc Natl Acad Sci USA 92: 10545-10549.
7. Cao Y, Semanchik N, Lee SH, et al. 2009. Chemical modifier screen identifies HDAC inhibitors as suppressors of PKD models. Proc Natl Acad Sci USA 106: 21819-21824.
8. Chakraborty C, Hsu CH, Wen ZH, et al. 2009. Zebrafish: a complete animal model for in vivo drug discovery and development. Curr Drug Metab 10: 116-124.
9. Chico TJA, Ingham PW, Crossman DC. 2008. Modeling cardiovascular disease in the zebrafish. Trends Cardiovasc Med 18: 150-155.
10. Coffin AB, Ou H, Owens KN, et al. 2010. Chemical screening for hair cell loss and protection in the zebrafish lateral line. Zebrafish 7: 3-11.
11. Crawford AD, Liekens S, Kamuhabwa AR, et al. 2011. Zebrafish bioassay-guided natural product discovery: isolation of angiogenesis inhibitors from east African medicinal plants. PloS one 6: e14694.
12. d'Alencon CA, Pena OA, Wittmann C, et al. 2010. A high-throughput chemically induced inflammation assay in zebrafish. BMC Biol 8: 151.
13. Egan RJ, Bergner CL, Hart PC, et al. 2009. Understanding behavioral and physiological phenotypes of stress and anxiety in zebrafish. Behav Brain Res 205: 38-44.
14. Ellett F, Lieschke GJ. 2010. Zebrafish as a model for vertebrate hematopoiesis. Curr Opin Pharmacol 10: 563-570.
15. Ewan K, Paja{ogonek}k B, Stubbs M, et al. 2010. A useful approach to identify novel small-molecule inhibitors of wnt-dependent transcription. Cancer Res 70: 5963-5973.
16. Flausino FJ, Santos LÁ, Verli H, et al. 2007. Anxiolytic effects of erythrinian alkaloids from Erythrina mulungu. J Nat Prod 70: 48-53.
17. Gehrig J, Reischl M, Kalmár É, et al. 2009. Automated high-throughput mapping of promoter-enhancer interactions in zebrafish embryos. Nat Methods 6: 911-916.
18. Gerlai R. 2010. High-throughput behavioral screens: the first step towards finding genes involved in vertebrate brain function using zebrafish. Molecules 15: 2609-2622.
19. Graf SF, Hötzel S, Liebel U, et al. 2011. Image-based fluidic sorting system for automated zebrafish egg sorting into multiwell plates. J Lab Autom 16: 105-111.
20. Granato M, Van Eeden F, Schach U, et al. 1996. Genes controlling and mediating locomotion behavior of the zebrafish embryo and larva. Development 123: 399-413.
21. Guo S. 2009. Using zebrafish to assess the impact of drugs on neural development and function. Expert Opin Drug Discov 4: 715-726.
22. Hao J, Ho JN, Lewis JA, et al. 2010. In vivo structure-activity relationship study of dorsomorphin analogues identifies selective VEGF and BMP inhibitors. ACS Chem Biol 5: 245-253.
23. Hong CC. 2009. Large-scale small-molecule screen using zebrafish embryos. Methods Mol Biol 486: 43-55.
24. Irons TD, MacPhail RC, Hunter DL, Padilla S. 2010. Acute neuroactive drug exposures alter locomotor activity in larval zebrafish. Neurotoxicol Teratol 32: 84-90.
25. Jagadeeswaran P, Paris R, Rao P. 2006. Laser-induced thrombosis in zebrafish larvae: a novel genetic screening method for thrombosis. Methods Mol Med 129: 187-195.
26. Jones KS, Alimov AP, Rilo HL, et al. 2008. A high throughput live transparent animal bioassay to identify non-toxic small molecules or genes that regulate vertebrate fat metabolism for obesity drug development. Nutr Metab 5: 23.
27. Kaufman CK, White RM, Zon L. 2009. Chemical genetic screening in the zebrafish embryo. Nat Protoc 4: 1422-1432.
28. Kawahara G, Karpf JA, Myers JA, et al. 2011. Drug screening in a zebrafish model of duchenne muscular dystrophy. Proc Natl Acad Sci USA 108: 5331-5336.
29. Kawakami K, Shima A, Kawakami N. 2000. Identification of a functional transposase of the Tol2 element, an ac-like element from the Japanese medaka fish, and its transposition in the zebrafish germ lineage. Proc Natl Acad Sci USA 97: 11403-11408.
30. Kokel D, Bryan J, Laggner C, et al. 2010. Rapid behavior-based identification of neuroactive small molecules in the zebrafish. Nat Chem Biol 6: 231-237.
31. Lang M, Gihr G, Gawaz M, Müller I. 2010. Hemostasis in Danio rerio: is the zebrafish a useful model for platelet research? J Thromb Haemost 8: 1159-1169.
32. Lawson ND, Weinstein BM. 2002. In vivo imaging of embryonic vascular development using transgenic zebrafish. Dev Biol 248: 307-318.
33. Lessman CA. 1999. Oogenesis, in nonmammalian vertebrates. In: Knobil E andNeill JD, editors. Encyclopedia of reproduction. New York: Academic Press. pp. 498-508.
34. Lessman CA. 2002. Use of computer-aided screening for detection of motility mutants in zebrafish embryos. Real-Time Imaging 8: 189-201.
35. Lessman CA. 2004. Computer-aided screening for zebrafish embryonic motility mutants. Methods Cell Biol 76: 285-313.
36. Lessman CA. 2009. Oocyte maturation: converting the zebrafish oocyte to the fertilizable egg. Gen Comp Endocrinol 161: 53-57.
37. Lessman CA, Nathani R, Uddin R, et al. 2007. Computer-aided meiotic maturation assay (CAMMA) of zebrafish (Danio rerio) oocytes in vitro. Mol Reprod Dev 74: 99-109.
38. Lessman CA, Taylor MR, Orisme W, Carver EA. 2010. Use of flatbed transparency scanners in zebrafish research: versatile and economical adjuncts to traditional imaging tools for the Danio rerio laboratory. Methods Cell Biol 100: 295-322.
39. Lockwood B, Bjerke S, Kobayashi K, Guo S. 2004. Acute effects of alcohol on larval zebrafish: a genetic system for large-scale screening. Pharmacol Biochem Behav 77: 647-654.
40. Love DR, Pichler FB, Dodd A, et al. 2004. Technology for high-throughput screens: the present and future using zebrafish. Curr Opin Biotechnol 15: 564-571.
41. Mandrekar N, Thakur NL. 2009. Significance of the zebrafish model in the discovery of bioactive molecules from nature. Biotechnol Lett 31: 171-179.
42. Milan DJ, Kim AM, Winterfield JR, et al. 2009. Drug-sensitized zebrafish screen identifies multiple genes, including GINS3, as regulators of myocardial repolarization. Circulation 120: 553-559.
43. Molina G, Vogt A, Bakan A, et al. 2009. Zebrafish chemical screening reveals an inhibitor of Dusp6 that expands cardiac cell lineages. Nat Chem Biol 5: 680-687.
44. Molina GA, Watkins SC, Tsang M. 2007. Generation of FGF reporter transgenic zebrafish and their utility in chemical screens. BMC Dev Biol 7: 62.
45. Murphey RD, Stern HM, Straub CT, Zon LI. 2006. A chemical genetic screen for cell cycle inhibitors in zebrafish embryos. Chem Biol Drug Des 68: 213-219.
46. Murphey R, Zon L. 2006. Small molecule screening in the zebrafish. Methods 39: 255-261.
47. Muto A, Orger MB, Wehman AM, et al. 2005. Forward genetic analysis of visual behavior in zebrafish. PLoS Genet 1: e66.
48. Oehlers SH, Flores MV, Okuda KS, et al. 2011. A chemical enterocolitis model in zebrafish larvae that is dependent on microbiota and responsive to pharmacological agents. Dev Dyn 240: 288-298.
49. Oppedal D, Goldsmith MI. 2010. A chemical screen to identify novel inhibitors of fin regeneration in zebrafish. Zebrafish 7: 53-60.
50. Pardo-Martin C, Chang TY, Koo BK, et al. 2010. High-throughput in vivo vertebrate screening. Nat Methods 7: 634-636.
51. Peal DS, Mills RW, Lynch SN, et al. 2011. Novel chemical suppressors of long QT syndrome identified by an in vivo functional screen. Circulation 123: 23-30.
52. Pelkowski SD, Kapoor M, Richendrfer HA, et al. 2011. A novel high-throughput imaging system for automated analyses of avoidance behavior in zebrafish larvae. Behav Brain Res 223: 135-144.
53. Peravali R, Gehrig J, Giselbrecht S, et al. 2011. Automated feature detection and imaging for high-resolution screening of zebrafish embryos. BioTechniques 50: 319-324.
54. Pereira TCB, Rico EP, Rosemberg DB, et al. 2011. Zebrafish as a model organism to evaluate drugs potentially able to modulate sirtuin expression. Zebrafish 8: 9-16.
55. Petzold AM, Bedell VM, Boczek NJ, et al. 2010. SCORE imaging: specimen in a corrected optical rotational enclosure. Zebrafish 7: 149-154.
56. Pruvot B, Jacquel A, Droin N, et al. 2011. Leukemic cell xenograft in zebrafish embryo for investigating drug efficacy. Haematologica 96: 612-615.
57. Rihel J, Prober DA, Arvanites A, et al. 2010. Zebrafish behavioral profiling links drugs to biological targets and rest/wake regulation. Science 327: 348-351.
58. Rinkwitz S, Mourrain P, Becker TS. 2011. Zebrafish: an integrative system for neurogenomics and neurosciences. Prog Neurobiol 93: 231-243.
59. Selman K, Petrino TR, Wallace RA. 1994. Experimental conditions for oocyte maturation in the zebrafish, Brachydanio rerio. J Exp Zool 269: 538-550.
60. Selman K, Wallace RA, Sarka A, Qi X. 1993. Stages of oocyte development in the zebrafish Brachydanio rerio. J Morphol 218: 203-224.
61. Snaar-Jagalska BE, ZF-CANCER Consortium 2009. ZF-CANCER: developing high-throughput bioassays for human cancers in zebrafish. Zebrafish 6: 441443.
62. Sun G, Pan J, Liu K, et al. 2010. Molecular cloning and expression analysis of P-selectin from zebrafish (Danio rerio). Int J Mol Sci 11: 4618-4630.
63. Sun Z, Amsterdam A, Pazour GJ, et al. 2004. A genetic screen in zebrafish identifies cilia genes as a principal cause of cystic kidney. Development 131: 4085-4093.
64. van Eeden FJ, Granato M, Odenthal J, Haffter P. 1999. Developmental mutant screens in the zebrafish. Methods Cell Biol 60: 21-41.
65. Vogt A, Cholewinski A, Shen X, et al. 2009. Automated image-based phenotypic analysis in zebrafish embryos. Dev Dyn 238: 656-663.
66. Westerfield M. 2004. The zebrafish book. A guide for the laboratory use of zebrafish (Danio rerio). 4th ed. Eugene: University of Oregon Press.
67. Wheeler GN, Brändli AW. 2009. Simple vertebrate models for chemical genetics and drug discovery screens: lessons from zebrafish and Xenopus. Dev Dyn 238: 1287-1308.
68. Williams CH, Hong CC. 2011. Multi-step usage of in vivo models during rational drug design and discovery. Int J Mol Sci 12: 2262-2274.
69. Yang L, Ho NY, Alshut R, et al. 2009. Zebrafish embryos as models for embryotoxic and teratological effects of chemicals. Reprod Toxicol 28: 245-253.